Among 177 carbapenemase-producing Gram-negative bacilli (108 KPC, 32 NDM, 11 IMP, 8 OXA-48, 4 OXA-181, 2 OXA-232, 5 IMI, 4 VIM, and 3 SME producers), aztreonam-avibactam was active against all isolates except two NDM producers with elevated MICs of 8/4 and 16/4 mg/liter; ceftazidime-avibactam was active against all KPC-, IMI-, SME-, and most OXA-48 group-producing isolates (93%) but not metallo-β-lactamase producers. Among older and contemporary antimicrobials, the most active were colistin, tigecycline, and fosfomycin, with overall susceptibilities of 88%, 79%, and 78%, respectively.
In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.
头孢他啶-阿维巴坦、氨曲南-阿维巴坦以及一系列老牌和现代抗菌药物对产碳青霉烯酶革兰氏阴性杆菌的体外活性
阅读:13
作者:Vasoo Shawn, Cunningham Scott A, Cole Nicolynn C, Kohner Peggy C, Menon Sanjay R, Krause Kevin M, Harris Kelly A, De Partha P, Koh Tse Hsien, Patel Robin
| 期刊: | Antimicrobial Agents and Chemotherapy | 影响因子: | 4.500 |
| 时间: | 2015 | 起止号: | 2015 Dec;59(12):7842-6 |
| doi: | 10.1128/AAC.02019-15 | 研究方向: | 微生物学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
